Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PROSTACYCLIN ANALOG' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 156 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Sobal, G; Sinzinger, H
      Prostaglandins and lipid modification

      CURRENT PHARMACEUTICAL DESIGN
    2. Wilkins, MR; Wharton, J
      Progress in, and future prospects for, the treatment of primary pulmonary hypertension

      HEART
    3. Bailey, CL; Channick, RN; Rubin, LJ
      A new era in the treatment of primary pulmonary hypertension

      HEART
    4. Rosenzweig, EB; Barst, RJ
      Novel therapeutics for the treatment of paediatric pulmonary arterial hypertension

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    5. Wigley, FM; Sule, SD
      Novel therapy in the treatment of scleroderma

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    6. Galie, N
      Do we need controlled clinical trials in pulmonary arterial hypertension?

      EUROPEAN RESPIRATORY JOURNAL
    7. Ohmori, M; Kitoh, Y; Kawaguchi, A; Harada, K; Sugimoto, K; Fujimura, A
      Enhanced neutrophil superoxide anion production and its modification by beraprost sodium in spontaneously hypertensive rats

      AMERICAN JOURNAL OF HYPERTENSION
    8. Konno, S; Arai, I; Otani, K; Olmarker, K; Kikuchi, S
      Effects of beraprost sodium on canine cauda equina function and blood flowusing a chronic spinal cord compression model

      JOURNAL OF SPINAL DISORDERS
    9. Vayssairat, M; Abdoucheli-Baudot, N; Gaitz, JP
      Treatments of progressive systemic sclerosis

      JOURNAL DES MALADIES VASCULAIRES
    10. Sorbera, LA; Rabasseda, X; Castaner, J
      UT-15 - Treatment of pulmonary hypertension, treatment of peripheral vascular disease

      DRUGS OF THE FUTURE
    11. Barst, RJ
      Medical therapy of pulmonary hypertension - An overview of treatment and goals

      CLINICS IN CHEST MEDICINE
    12. Channick, RN; Rubin, LJ
      New and experimental therapies for pulmonary hypertension

      CLINICS IN CHEST MEDICINE
    13. Channick, RN; Simonneau, G; Sitbon, O; Robbins, IM; Frost, A; Tapson, VF; Badesch, DB; Roux, S; Rainisio, M; Bodin, F; Rubin, LJ
      Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study

      LANCET
    14. Hirano, T; Nakafusa, Y; Kawano, R; Motoyama, K; Arima, T; Sugitani, A; Tanaka, M
      The combined use of prostaglandin I-2 analogue (OP-2507) and thromboxane A(2) synthetase inhibitor (OKY-046) strongly inhibits atherosclerosis of aortic allografts in rats

      SURGERY
    15. Stratton, R; Xu, SW; Martini, G; Holmes, A; Leask, A; Haberberger, T; Martin, GR; Black, CM; Abraham, D
      Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients

      JOURNAL OF CLINICAL INVESTIGATION
    16. Ariad, S; Argov, S; Manor, E; Yermiahu, T; Kedar, I
      Acute blast crisis with EBV-infected blasts, in a patient with chronic myeloid leukemia, and vasculitis

      LEUKEMIA & LYMPHOMA
    17. Wakita, H; Yoshiwara, H; Kitano, Y; Nishiyama, H; Nagase, H
      Preparative resolution of 2-methyl-4-hexynic acid for the synthesis of optically active m-phenylene PGI(2) derivatives and determination of their absolute configuration

      TETRAHEDRON-ASYMMETRY
    18. Nishimura, T; Yamamoto, T; Ueda, Y; Yamada, K; Hara, Y
      Stable prostaglandin I-1 analog SM-10906 modulates productions of tumor necrosis factor-alpha, interleukin-1 and interleukin-6 in mouse macrophages

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    19. Kunieda, T
      Diagnosis and treatment of pulmonary hypertension associated with collagendiseases

      INTERNAL MEDICINE
    20. Ooiwa, H; Miyazawa, T; Yamanishi, Y; Hiyama, K; Ishioka, S; Yamakido, M
      Successful treatment of systemic lupus erythematosus and pulmonary hypertension with intravenous prostaglandin I-2 followed by its oral analogue

      INTERNAL MEDICINE
    21. Taoka, Y; Okajima, K
      Role of leukocytes in spinal cord injury in rats

      JOURNAL OF NEUROTRAUMA
    22. Warot, D; Berlin, I; Aymard, G; Ankri, A; Fabry, C; Besse, B; Lechat, P; Diquet, B
      Beraprost sodium-fluindione combination in healthy subjects: pharmacokinetic and pharmacodynamic aspects

      FUNDAMENTAL & CLINICAL PHARMACOLOGY
    23. Duthois, S; Cailleux, N; Levesque, H
      Tolerance and therapeutic results of iloprost in severe chronic ischemia of the lower limbs. A report on 90 patients.

      JOURNAL DES MALADIES VASCULAIRES
    24. Trager, K; Matejovic, M; Zulke, C; Vlatten, A; Vogt, J; Wachter, U; Altherr, J; Brinkmann, A; Jauch, KW; Georgieff, M; Radermacher, P
      Hepatic O-2 exchange and liver energy metabolism in hyperdynamic porcine endotoxemia: effects of iloprost

      INTENSIVE CARE MEDICINE
    25. Ueno, M; Miyauchi, T; Sakai, S; Goto, K; Yamaguchi, I
      Endothelin-A-receptor antagonist and oral prostacyclin analog are comparably effective in ameliorating pulmonary hypertension and right ventricular hypertrophy in rats

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    26. Kishimoto, S; Sakon, M; Umeshita, K; Miyoshi, H; Taniguchi, K; Meng, W; Nagano, H; Dono, K; Ariyosi, H; Nakamori, S; Kawasaki, T; Gotoh, M; Monden, M; Imajoh-Ohmi, S
      The inhibitory effect of prostaglandin E-1 on oxidative stress-induced hepatocyte injury evaluated by calpain-mu activation

      TRANSPLANTATION
    27. Nagano, K; Toba, K; Akishita, M; Watanabe, T; Kozaki, K; Eto, M; Hashimoto, M; Sudoh, N; Ako, J; Yoshizumi, M; Ouchi, Y
      Prostanoids regulate proliferation of vascular smooth muscle cells inducedby arginine vasopressin

      EUROPEAN JOURNAL OF PHARMACOLOGY
    28. Frid, MG; Aldashev, AA; Nemenoff, RA; Higashito, R; Westcott, JY; Stenmark, KR
      Subendothelial cells from normal bovine arteries exhibit autonomous growthand constitutively activated intracellular signaling

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    29. Fitzl, G; Winkler, D; Wassilev, G; Welt, K
      The protective effect of Iloprost, a PGL2-analogue, on ultrastructure of ischemic and reperfused myocardial myocytes

      EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
    30. Arita, S; Kasraie, A; Une, S; Ohtsuka, S; Kawahara, T; Smith, CV; Mullen, Y
      Improved recovery of cryopreserved canine islets by use of beraprost sodium

      PANCREAS
    31. Sava, G; Bergamo, A
      Drug control of solid tumour metastases: A critical view

      ANTICANCER RESEARCH
    32. Roy, S; Brosstad, F; Sakariassen, KS
      Selective thrombolysis in acute deep vein thrombosis: Evaluation of adjuvant therapy in vivo

      CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
    33. Yang, LB; Yatomi, Y; Satoh, K; Ozaki, Y
      Inhibitory effects of beraprost on platelet aggregation: Comparative studyutilizing two methods of aggregometry

      THROMBOSIS RESEARCH
    34. Kozek-Langenecker, SA
      Anticoagulation with prostaglandins during extracorporeal circulation

      WIENER KLINISCHE WOCHENSCHRIFT
    35. Sobal, G; Sinzinger, H
      Effects of PGI(2) and analogues (taprostene, iloprost) on oxidation of native and glycated LDL

      LIFE SCIENCES
    36. Braun, J; Sieper, J; Riemekasten, G; Hiepe, F
      Iloprost treatment in systemic sclerosis: comment on the concise communication by Tedeschi et al

      ARTHRITIS AND RHEUMATISM
    37. Hejna, M; Raderer, M; Zielinski, CC
      Inhibition of metastases by anticoagulants

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    38. VAULONT I; GAIS HJ; REUTER N; SCHMITZ E; OSSENKAMP RKL
      ASYMMETRIC-SYNTHESIS OF 3-OXACARBACYCLIN AND 3-OXAISOCARBACYCLIN BY ACOMMON ENANTIOSELECTIVE DEPROTONATION BASED ROUTE

      EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
    39. VANGIEZEN JJJ; REITSMA JH; BOUMA BN; HASSELAAR P; REINDERS JH; JANSEN JWCM
      FUROSEMIDE ENHANCES BLOOD FIBRINOLYTIC-ACTIVITY IN RATS WITH NO CORRELATION TO ITS DIURETIC ACTIVITY

      FIBRINOLYSIS & PROTEOLYSIS
    40. Biasi, D; Carletto, A; Caramaschi, P; Zeminian, S; Pacor, ML; Corrocher, R; Bambara, LM
      Iloprost as cyclic five-day infusions in the treatment of scleroderma - Anopen pilot study in 20 patients treated for one year

      REVUE DU RHUMATISME
    41. TANAKA H; MATSUI S; SHIGENOBU K
      CARDIOPROTECTIVE EFFECTS OF BERAPROST SODIUM AGAINST EXPERIMENTAL-ISCHEMIA AND REPERFUSION AS COMPARED WITH PROPRANOLOL AND DILTIAZEM

      Research communications in molecular pathology and pharmacology
    42. BURNARD SL; MCMURCHIE EJ; LEIFERT WR; PATTEN GS; MUGGLI R; RAEDERSTORFF D; HEAD RJ
      CILAZAPRIL AND DIETARY GAMMA-LINOLENIC ACID PREVENT THE DEFICIT IN SCIATIC-NERVE CONDUCTION-VELOCITY IN THE STREPTOZOTOCIN-DIABETIC RAT

      Journal of diabetes and its complications
    43. ICHIDA F; UESE K; TSUBATA S; HASHIMOTO I; HAMAMICHI Y; FUKAHARA K; MURAKAMI A; MIYAWAKI T
      BENEFICIAL EFFECT OF AN ORAL ANALOG OF PROSTACYCLIN ON PULMONARY-HYPERTENSION SECONDARY TO CONGENITAL HEART-DISEASE

      Cardiology in the young
    44. KURUVILLA R; PETERSON RG; KINCAID JC; EICHBERG J
      EVENING PRIMROSE OIL TREATMENT CORRECTS REDUCED CONDUCTION-VELOCITY BUT NOT DEPLETION OF ARACHIDONIC-ACID IN NERVE FROM STREPTOZOTOCIN-INDUCED DIABETIC RATS

      Prostaglandins, leukotrienes and essential fatty acids
    45. RADAUCEANU A; AVIGNON A; RIBSTEIN J; MONNIER L
      USE OF A PROSTACYCLIN ANALOG IN CHOLESTEROL CRYSTAL EMBOLISM

      Diabetic medicine
    46. DIMITROFF CJ; SHARMA A; BERNACKI RJ
      CANCER METASTASIS - A SEARCH FOR THERAPEUTIC INHIBITION

      Cancer investigation
    47. ICHIDA F; UESE KI; HAMAMICHI Y; HASHIMOTO I; TSUBATA SI; FUKAHARA K; MURAKAMI A; MIYAWAKI T
      CHRONIC EFFECTS OF ORAL PROSTACYCLIN ANALOG ON THROMBOXANE A(2) AND PROSTACYCLIN METABOLITES IN PULMONARY-HYPERTENSION

      Acta Paediatrica Japonica Overseas Edition
    48. EVANS DH; GUNDERSON MP
      A PROSTAGLANDIN, NOT NO, MEDIATES ENDOTHELIUM-DEPENDENT DILATION IN VENTRAL AORTA OF SHARK (SQUALUS-ACANTHIAS)

      American journal of physiology. Regulatory, integrative and comparative physiology
    49. RIEMEKASTEN G; JEPSEN H; BURMESTER GR; HIEPE F
      3 WEEK ILOPROST-THERAPY AS AN EFFECTIVE T REATMENT OF PSS - CASE-REPORT AND LITERATURE REFERENCE REVIEW

      Zeitschrift fur Rheumatologie
    50. TAOKA Y; OKAJIMA K
      SPINAL-CORD INJURY IN THE RAT

      Progress in neurobiology
    51. BLACK CM; HALKIERSORENSEN L; BELCH JJF; ULLMAN S; MADHOK R; SMIT AJ; BANGA JD; WATSON HR
      ORAL ILOPROST IN RAYNAUDS-PHENOMENON SECONDARY TO SYSTEMIC-SCLEROSIS - A MULTICENTER, PLACEBO-CONTROLLED, DOSE-COMPARISON STUDY

      British journal of rheumatology (Print)
    52. LEVIN M; NAKHOUL F; KEIDAR Z; GREEN J
      ACUTE OLIGURIC RENAL-FAILURE ASSOCIATED WITH UNILATERAL RENAL EMBOLISM - A SUCCESSFUL TREATMENT WITH ILOPROST

      American journal of nephrology
    53. DREWS G; DECKERT F; WITZIGMANN H; HAUSS J; SPIEGEL HU
      INFLUENCE OF RAPID COOLING ON MICROPERFUS ION OF DONOR LIVERS

      Zentralblatt fur Chirurgie
    54. LO CJ; FU MJ; LO FR
      PROSTAGLANDIN I-2 ANALOG, ILOPROST, DOWN-REGULATES MITOGEN-ACTIVATED PROTEIN-KINASES OF MACROPHAGES

      The Journal of surgical research (Print)
    55. Inada, H; Shindo, H; Tawata, M; Onaya, T
      cAMP regulates nitric oxide production and ouabain sensitive Na+, K+-ATPase activity in SH-SY5Y human neuroblastoma cells

      DIABETOLOGIA
    56. SUH BY; KWUN KB; KWUN TW; KIM SK; YOON JO; YAMAMOTO M
      OPEN-LABEL, UNCONTROLLED, 6-WEEK CLINICAL-TRIAL OF BERAPROST IN PATIENTS WITH CHRONIC OCCLUSIVE ARTERIAL-DISEASE

      Current therapeutic research
    57. WIGLEY FM; KORN JH; CSUKA ME; MEDSGER TA; ROTHFIELD NF; ELLMAN M; MARTIN R; COLLIER DH; WEINSTEIN A; FURST DE; JIMENEZ SA; MAYES MD; MERKEL PA; GRUBER B; KAUFMAN L; VARGA J; BELL P; KERN J; MARROTT P; WHITE B; SIMMS RW; PHILLIPS AC; SEIBOLD JR
      ORAL ILOPROST TREATMENT IN PATIENTS WITH RAYNAUDS-PHENOMENON SECONDARY TO SYSTEMIC-SCLEROSIS - A MULTICENTER, PLACEBO-CONTROLLED DOUBLE-BLIND STUDY

      Arthritis and rheumatism
    58. TEDESCHI A; MERONI PL; DELPAPA N; SALMASO C; BOSCHETTI C; MIADONNA A
      THROMBOTIC EVENTS IN PATIENTS WITH SYSTEMIC-SCLEROSIS TREATED WITH ILOPROST

      Arthritis and rheumatism
    59. BLEY KR; HUNTER JC; EGLEN RM; SMITH JAM
      THE ROLE OF IP PROSTANOID RECEPTORS IN INFLAMMATORY PAIN

      Trends in pharmacological sciences
    60. KANDARPA K; NAKATSUKA S; BRAVO SM; HARAPANHALLI RS; BARRY JJ
      MURAL DELIVERY OF ILOPROST WITH USE OF HYDROGEL-COATED BALLOON CATHETERS SUPPRESSES LOCAL PLATELET-AGGREGATION

      Journal of vascular and interventional radiology
    61. UESE K; ICHIDA F; TSUBATA S; HASHIMOTO I; HAMAMICHI Y; FUKAHARA K; MURAKAMI A; MIYAWAKI T
      ORAL PROSTACYCLIN ENHANCES THE PULMONARY VASODILATORY EFFECT OF NITRIC-OXIDE IN CHILDREN WITH PULMONARY-HYPERTENSION

      Cardiology in the young
    62. GAIS HJ; SCHMIEDL G; OSSENKAMP RKL
      TOTAL SYNTHESIS OF (-3-OXACARBACYCLIN - 1 - RETROSYNTHESIS AND ASYMMETRIC OLEFINATION THROUGH HORNER-WADSWORTH-EMMONS, PETERSON AND MARTIN REACTIONS())

      Liebigs Annalen
    63. JUNG S; DONHAUSER T; TOYKA KV; HARTUNG HP
      PROPENTOFYLLINE AND ILOPROST SUPPRESS THE PRODUCTION OF TNF-ALPHA BY MACROPHAGES BUT FAIL TO AMELIORATE EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS IN LEWIS RATS

      Journal of autoimmunity
    64. BIASI D; CARAMASCHI P; CARLETTO A; ZEMINIAN S; SCHIAVON F; BAMBARA LM
      A CASE OF DIFFUSE SYSTEMIC-SCLEROSIS TREATED WITH A 28-DAY INFUSION OF ILOPROST

      Clinical rheumatology
    65. SCHIRNER M; SCHNEIDER MR
      INHIBITION OF METASTASIS BY CICAPROST IN RATS WITH ESTABLISHED SMT2A MAMMARY-CARCINOMA GROWTH

      Cancer detection and prevention
    66. MAULIK M; SETH SD; MANCHANDA SC; MAULIK SK
      LACK OF ANY ADDITIONAL BENEFIT IN COMBINING ASPIRIN WITH ILOPROST IN A CANINE MODEL OF MYOCARDIAL REPERFUSION INJURY

      Prostaglandins
    67. UENO Y; KOIKE H; ANNOH S; NISHIO S
      ANTIINFLAMMATORY EFFECTS OF BERAPROST SODIUM, A STABLE ANALOG OF PGI(2), AND ITS MECHANISMS

      Prostaglandins
    68. MANASIA A; KANG H; HANNON E; LU YZ; OROPELLO J; LEIBOWITZ A; STEIN J; BENJAMIN E
      EFFECTS OF THE STABLE PROSTACYCLIN ANALOG ILOPROST ON MESENTERIC BLOOD-FLOW IN PORCINE ENDOTOXIC-SHOCK

      Critical care medicine
    69. TERAOKA S; OTA K; TANABE K; TAKAHASHI K; TOMA H; YASUMURA T; YOSHIMURA N; OKA T; TAKAHARA S; OKUYAMA A; HABA T; UCHIDA K; SUGIYAMA S; OHSHIMA S; SATO T; OKAZAKI H; MOROZUMI K
      MULTICENTER TRIAL OF THE THERAPEUTIC EFFECT OF A NEWLY DEVELOPED ANTIPLATELET AGENT, SATIGREL, ON BIOPSY-PROVEN CHRONIC REJECTION AFTER KIDNEY-TRANSPLANTATION

      Transplantation proceedings
    70. HILDEBRAND M
      PHARMACOKINETICS AND TOLERABILITY OF ORAL ILOPROST IN THROMBOANGIITIS-OBLITERANS PATIENTS

      European Journal of Clinical Pharmacology
    71. TRIFILETTI A; SCAMARDI R; PIZZOLEO MA; NEVOSO A; SORACI S; BARTOLONE S; BAGNATO L; BARBERA N
      HEMOSTATIC EFFECTS OF ILOPROST IN PATIENTS WITH LOWER-LIMB ISCHEMIA

      Panminerva Medica
    72. OCHIAI H; NAKAMURA S; SUZUKI S; BABA S; BABA S
      PANCREATIC DAMAGE RESULTING FROM TEMPORARY PORTAL TRIAD INTERRUPTION DURING PARTIAL-HEPATECTOMY - PROTECTIVE EFFECT OF A PROSTAGLANDIN I-2 ANALOG

      The Journal of surgical research
    73. HIROI T; MARUYAMA K; HATTORI K; OHNUKI T; NAGATOMO T; WATANABE K; YAMAMOTO T; HARA Y
      AFFINITY FOR [H-3] ILOPROST BINDING-SITES AND CAMP SYNTHESIS ACTIVITYOF A 3-OXA-METHANO PROSTAGLANDIN I-1 ANALOG, SM-10906, IN HUMAN PLATELETS AND ENDOTHELIAL-CELLS

      Japanese Journal of Pharmacology
    74. VARELAAGUILAR JM; SANCHEZROMAN J; MELENDEZ AT; PALMA MJC
      COMPARATIVE-STUDY OF MISOPROSTOL AND NIFE DIPINE FOR THE TREATMENT OFRAYNAUD PHENOMENON SECONDARY TO SYSTEMIC-DISEASES - DOPPLER-DUPLEX HEMODYNAMIC EVALUATION

      Revista Clinica Espanola
    75. CAMERON NE; COTTER MA
      METABOLIC AND VASCULAR FACTORS IN THE PATHOGENESIS OF DIABETIC NEUROPATHY

      Diabetes
    76. BATTAL MN; HATA Y
      BERAPROST SODIUM - A STABLE PROSTAGLANDIN I-2 ANALOG

      British Journal of Plastic Surgery
    77. YAE T; ARAKI H; OOGAMI Y; IWASAKI K; TANABE H; FUJIWARA M
      EFFECTS OF THE ISOCARBACYCLIN METHYL-ESTER CLINPROST INCORPORATED INTO LIPID MICROSPHERES, IN FOCAL ISCHEMIA OF STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS

      Arzneimittel-Forschung
    78. JIANG WG; MANSEL RE
      PROGRESS IN ANTI-INVASION AND ANTI-METASTASIS RESEARCH AND TREATMENT

      International journal of oncology
    79. KLEIMAN NS
      CLINICAL-TRIALS OF CONJUNCTIVE ANTICOAGULANT STRATEGIES IN THROMBOLYSIS

      Coronary artery disease
    80. HASHIMOTO S; MIYAZAKI Y; IKEGAMI S
      A REGIOCONTROLLED AND STEREOCONTROLLED SYNTHESIS OF 13,14-DIDEHYDROISOCARBACYCLIN

      Synlett
    81. ALEXANDROU K; HATA Y; MATSUKA K; MATSUDA H
      THE EFFECT OF WASHOUT PERFUSION WITH BERAPROST SODIUM ON THE NO-REFLOW PHENOMENON IN THE RAT ISLAND FLAP

      European journal of plastic surgery
    82. RUWART MJ; HENLEY KS
      PROSTAGLANDINS IN LIVER-DISEASE AND LIVER-TRANSPLANTATION

      Gastroenterology clinics of North America
    83. ALEXANDROU K; HATA Y; MATSUKA K; ITO O; MATSUDA H; FURUICHI H; ISHIZU N
      THE EFFECT OF BERAPROST SODIUM ON THE SURVIVAL OF SUBCUTANEOUS TRANSFERRED JEJUNUM AFTER VASCULAR PEDICLE INTERRUPTION IN A RAT MODEL

      Journal of reconstructive microsurgery
    84. TAKAGAKI M; HISAMOCHI K; MORIMOTO T; BANDO K; SANO S; SHIMIZU N
      TRANSPLANTATION OF THE CADAVER HEART HARVESTED ONE-HOUR AFTER HYPOXICCARDIAC-ARREST USING THE CORE-COOLING TECHNIQUE IN DOGS

      Acta medica Okayama
    85. OKANO K; KOKUDO Y; OKAJIMA K; HOSSAIN MA; ISHIMURA K; YACHIDA S; TSUBOUCHI T; WAKABAYASHI H; MAEBA T; MAETA H
      PROTECTIVE EFFECTS OF ANTITHROMBIN-III SUPPLEMENTATION ON WARM ISCHEMIA AND REPERFUSION INJURY IN RAT-LIVER

      World journal of surgery
    86. SUGIURA S; KUROZUMI S
      PROSTAGLANDIN CHEMISTRY .40. SYNTHESIS OF TRITIUM-LABELED ISOCARBACYCLIN DERIVATIVES, RADIOLABELED PROSTAGLANDIN I-1 ANALOGS .1.

      Journal of labelled compounds & radiopharmaceuticals
    87. UENO Y; YAMADA N; KOIKE H; NISHIO S
      EFFECTS OF BERAPROST SODIUM AND PROSTAGLANDIN E(1) SKIN BLOOD-FLOW INDIABETIC RATS AND NORMAL DOGS

      General pharmacology
    88. BATTAL MN; HATA Y; MATSUKA K; ITO O; MATSUDA H; YOSHIDA Y; KAWAZOE T
      REDUCTION OF PROGRESSIVE BURN INJURY BY A STABLE PROSTAGLANDIN I-2 ANALOG, BERAPROST SODIUM (PROCYLIN) - AN EXPERIMENTAL-STUDY IN RATS

      Burns
    89. HEINZ M; THEISS W; VANDEFLIERDT E; SOHNGEN M
      THE EFFECT OF TAPROSTENE ON PLATELET UPTA KE RATIO AND CLINICAL OUTCOME AFTER PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY

      VASA
    90. ALEXANDROU K; HATA Y; MATSUKA K; MATSUDA H
      EFFECT OF BERAPROST SODIUM (PROCYLIN(TM)), A STABLE PROSTAGLANDIN I-2ANALOG, ON A DORSAL SKIN FLAP MODEL IN RATS

      Scandinavian journal of plastic and reconstructive surgery and hand surgery
    91. BARTOSIK I; ESKILSSON J; SCHEJA A; AKESSON A
      INTERMITTENT ILOPROST INFUSION THERAPY OF PULMONARY-HYPERTENSION IN SCLERODERMA - A PILOT-STUDY

      British journal of rheumatology
    92. SCHNEIDER MR; SCHIRNER M; LICHTNER RB; GRAF H
      ANTIMETASTATIC ACTION OF THE PROSTACYCLIN ANALOG CICAPROST IN EXPERIMENTAL MAMMARY-TUMORS

      Breast cancer research and treatment
    93. LIEVRE M; AZOULAY S; LION L; MORAND S; GIRRE JP
      A DOSE-EFFECT STUDY OF BERAPROST SODIUM IN INTERMITTENT CLAUDICATION

      Journal of cardiovascular pharmacology
    94. HAYASHI J; ISHIDA N; SATO H; HATA Y; SAITO T
      EFFECT OF BERAPROST, A STABLE PROSTACYCLIN ANALOG, ON RED-BLOOD-CELL DEFORMABILITY IMPAIRMENT IN THE PRESENCE OF HYPERCHOLESTEROLEMIA IN RABBITS

      Journal of cardiovascular pharmacology
    95. GEERLING RA; DEBRUIN RWF; SCHERINGA M; BONTHUIS F; IJZERMANS JNM; MARQUET RL
      KETANSERIN REDUCES GRAFT ARTERIOSCLEROSIS AFTER ALLOGENEIC AORTA TRANSPLANTATION IN RATS

      Journal of cardiovascular pharmacology
    96. WALDER CE; ERRETT CJ; BUNTING S; LINDQUIST P; OGEZ JR; HEINSOHN HG; FERRARA N; THOMAS GR
      VASCULAR ENDOTHELIAL GROWTH-FACTOR AUGMENTS MUSCLE BLOOD-FLOW AND FUNCTION IN A RABBIT MODEL OF CHRONIC HINDLIMB ISCHEMIA

      Journal of cardiovascular pharmacology
    97. OKUDA Y; SONE H; MIZUTANI S; ASANO M; TSURUSHIMA Y; OGAWA M; TADA K; ASAKURA Y; KAWAKAMI Y; SUZUKI S; YAMASHITA K
      ACUTE EFFECT OF BERAPROST SODIUM ON LOWER-LIMB CIRCULATION IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES MELLITUS-EVALUATION BY COLOR DOPPLER ULTRASONOGRAPHY AND LASER CUTANEOUS BLOOD FLOWMETRY

      Prostaglandins
    98. MISSELWITZ B; BRAUTIGAM M
      A COMPARATIVE-STUDY OF THE EFFECTS OF ILOPROST AND PGE(1) ON PULMONARY ARTERIAL-PRESSURE AND EDEMA FORMATION IN THE ISOLATED-PERFUSED RAT LUNG MODEL

      Prostaglandins
    99. MAKITA Y; SEKIZUKA K; WANG LN; FUKUI M; TOMINO Y
      EFFECT OF BERAPROST SODIUM, A PGI2 ANALOG, ON PROLIFERATION OF CULTURED RAT GLOMERULAR MESANGIAL CELLS

      Nephron
    100. WANG LN; TANG Z; SHOU I; FUKUI M; TOMINO Y
      EFFECTS OF THE PGI(2) ANALOG BERAPROST SODIUM ON GLOMERULAR PROSTANOID SYNTHESIS IN RATS WITH STREPTOZOTOCIN-INDUCED DIABETES

      Nephron


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 08/08/20 alle ore 15:13:21